Non-alcoholic fatty liver disease, not elsewhere classified (Q86648): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
DHGNA primária está associada a resistência a insulina. DHGNA secundária está associada a muitas condições como síndrome dos ovários policísticos, doenças endócrinas, apnéia do sono e ressecção pancreato-duodenal, etc. Medicações esteatogênicas não estão incluídas como uma causa de DHGNA. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Primary NAFLD is associated with insulin resistance. Secondary NAFLD is associated with many conditions such as polycystic ovary syndrome, endocrine diseases, sleep apnoea and pancreato-duodenal resection, etc. Steatogenic medications are not included as a cause of NAFLD. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1331941447 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_1331941447 | |||||||||||||||
| Property / CURIE: CID11:ID_1331941447 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_1331941447 | |||||||||||||||
| Property / Canary Token: dki-india-ID_1331941447 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 12:05, 15 August 2026
Primary NAFLD is associated with insulin resistance. Secondary NAFLD is associated with many conditions such as polycystic ovary syndrome, endocrine diseases, sleep apnoea and pancreato-duodenal resection, etc. Steatogenic medications are not included as a cause of NAFLD.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1331941447 |
||
| English | Non-alcoholic fatty liver disease, not elsewhere classified |
Primary NAFLD is associated with insulin resistance. Secondary NAFLD is associated with many conditions such as polycystic ovary syndrome, endocrine diseases, sleep apnoea and pancreato-duodenal resection, etc. Steatogenic medications are not included as a cause of NAFLD. |
Statements
CID11:ID_1331941447
0 references
dki-india-ID_1331941447
0 references
Concluído
0 references
13 August 2026
0 references
